MTOR and familial pancreatic carcinoma: PI3K/Akt/mTOR axis has already been established to play an essential role in CSC biology and mTOR inhibitors have been proved to eradicate CSCs in different human cancers (neuroblastoma, nasopharyngeal, colon, and pancreatic cancers).